Stifel Nicolaus reiterated their hold rating on shares of DBV TECHNOLOGIE/S (NASDAQ:DBVT) in a report published on Friday morning, AnalystRatings.com reports.

A number of other brokerages have also recently weighed in on DBVT. JMP Securities dropped their price objective on shares of DBV TECHNOLOGIE/S from $20.00 to $10.00 in a report on Tuesday, March 17th. Bryan, Garnier & Co cut shares of DBV TECHNOLOGIE/S from a buy rating to a neutral rating in a report on Wednesday, March 18th. ValuEngine upgraded shares of DBV TECHNOLOGIE/S from a hold rating to a buy rating in a report on Wednesday, March 11th. Citigroup dropped their price objective on shares of DBV TECHNOLOGIE/S from $14.00 to $10.00 and set a buy rating for the company in a report on Monday, April 6th. Finally, Morgan Stanley dropped their price objective on shares of DBV TECHNOLOGIE/S from $11.00 to $4.00 and set an equal weight rating for the company in a report on Wednesday, March 18th. Five research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. The stock currently has an average rating of Buy and a consensus target price of $10.21.

DBV TECHNOLOGIE/S stock opened at $4.63 on Friday. The company’s 50 day simple moving average is $5.19 and its 200-day simple moving average is $7.39. The company has a market capitalization of $511.92 million, a price-to-earnings ratio of -1.99 and a beta of 2.60. DBV TECHNOLOGIE/S has a 1 year low of $2.02 and a 1 year high of $13.49. The company has a debt-to-equity ratio of 0.12, a quick ratio of 3.75 and a current ratio of 3.79.

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. M&T Bank Corp grew its holdings in DBV TECHNOLOGIE/S by 13.0% during the 1st quarter. M&T Bank Corp now owns 17,460 shares of the company’s stock worth $68,000 after acquiring an additional 2,012 shares in the last quarter. Artisan Partners Limited Partnership grew its holdings in DBV TECHNOLOGIE/S by 2.6% during the 4th quarter. Artisan Partners Limited Partnership now owns 372,107 shares of the company’s stock worth $3,982,000 after acquiring an additional 9,494 shares in the last quarter. Geode Capital Management LLC grew its holdings in DBV TECHNOLOGIE/S by 55.9% during the 4th quarter. Geode Capital Management LLC now owns 28,997 shares of the company’s stock worth $310,000 after acquiring an additional 10,397 shares in the last quarter. Advisor Group Holdings Inc. acquired a new position in DBV TECHNOLOGIE/S during the 1st quarter worth approximately $43,000. Finally, Parametric Portfolio Associates LLC grew its holdings in DBV TECHNOLOGIE/S by 14.6% during the 1st quarter. Parametric Portfolio Associates LLC now owns 86,725 shares of the company’s stock worth $340,000 after acquiring an additional 11,033 shares in the last quarter. Institutional investors own 44.00% of the company’s stock.

About DBV TECHNOLOGIE/S

DBV Technologies SA, a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in children, adolescents, and adults.

See Also: What are popular green investing opportunities?

Analyst Recommendations for DBV TECHNOLOGIE/S (NASDAQ:DBVT)

Receive News & Ratings for DBV TECHNOLOGIE/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DBV TECHNOLOGIE/S and related companies with MarketBeat.com's FREE daily email newsletter.